Diagnostic evaluation of magnetization transfer and diffusion kurtosis imaging for prostate cancer detection in a

Tristan Barrett1,2,3, Mary McLean4, Andrew N Priest5

  • 1Department of Radiology, University of Cambridge, Cambridge, UK. tb507@medschl.cam.ac.uk.

European Radiology
|December 10, 2017
PubMed
Abstract

Insights

Diffusion kurtosis imaging (DKI) and magnetisation transfer imaging (MTI) show promise in distinguishing prostate tumors from benign tissue. However, these advanced MRI techniques cannot reliably differentiate between low- and high-grade prostate cancer.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Prostate cancer assessment often requires re-biopsy, which can be invasive.
  • Advanced MRI techniques like DKI and MTI may improve diagnostic accuracy.

Purpose of the Study:

  • To compare the efficacy of DKI and MTI against standard MRI for prostate cancer detection in patients undergoing re-biopsy.
  • To evaluate the ability of these advanced MRI techniques to differentiate tumor characteristics.

Main Methods:

  • Thirty patients underwent 3 Tesla MRI including DKI (Kapp, Dapp) and MTI (with/without saturation).
  • Patients had transperineal biopsy targeting MRI-identified lesions.
  • ROC analyses and Wilcoxon-signed ranked tests were used to assess imaging parameters.

Main Results:

  • Apparent diffusion coefficient (ADC) and Dapp were lower, while Kapp and MT ratio (MTR) were higher in tumors versus benign tissue (p ≤ 0.005).
  • Normal transition zone (TZ) tissue differed from peripheral zone (PZ) tissue in ADC, Dapp, Kapp, and MTR.
  • No significant difference was found between low-grade (Gleason 3+3) and high-grade (≥ 3+4) disease using any parameter.

Conclusions:

  • DKI and MTI parameters (ADC, Dapp, Kapp, MTR) effectively distinguish prostate tumors from benign tissue.
  • These advanced MRI techniques do not reliably differentiate between low- and high-grade prostate cancer.
  • Further research is needed to explore the potential of divergent MTR/DKI values in TZ tumors.